RG

Rashmi Grover

Director Director DIN 01029344
DIN 01029344 First appointment Sep 1999 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Sep 1999
Shareholding value Locked Premium profile

About Rashmi Grover

Rashmi Grover has 26 years in corporate governance. Formerly with 1 company, such as S S Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 01029344
Primary Designation Director
First Appointment 12 Sep 1999
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
S S Pharmaceuticals Private Limited U24231UP1982PTC005587
Director 12 Sep 1999 1982 Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
S S Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rashmi Grover

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rashmi Grover

Rashmi Grover has 26 years in corporate governance. Formerly with 1 company, such as S S Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Rashmi Grover is associated with 0 companies as a director.

Rashmi Grover has expertise in General Business.

Rashmi Grover has 26 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available